Standards, options and recommendations for nutritional support in adult patients with advanced or terminal cancer;Standards, options et recommandations: Nutrition en situation palliative ou terminale de l'adulte porteur de cancer évolutif

Bulletin du Cancer

Volumn 88, Issue 10, 2001, Pages 985-1006

  Bachmann, P ^a   Marti Massoud, C ^a   Blanc Vincent, M P ^a   Desport, J C ^a   Colomb, V ^a   Dieu, L ^a   Kere, D ^a   Melchior, J C ^a   Nitenberg, G ^a   Raynard, B ^a   Roux Bournay, P ^a   Schneider, S ^a   Senesse, P ^a  

^a FNCLCC   (France)

Author keywords

Cancer; Enteral nutrition; Guidelines; Neoplasms; Nutrition; Nutritional support; Palliative care; Parenteral nutrition; Quality of life; Terminal care

Indexed keywords

ADVANCED CANCER; ANOREXIA; ARTICLE; ARTIFICIAL FEEDING; CANCER PALLIATIVE THERAPY; CANCER PATIENT; DIETETICS; ENTERIC FEEDING; FRANCE; HEAD AND NECK CANCER; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; LIFE EXPECTANCY; NUTRITION; PARENTERAL NUTRITION; PATIENT COUNSELING; PATIENT SATISFACTION; PRACTICE GUIDELINE; PROGNOSIS; QUALITY OF LIFE; SCORING SYSTEM; TERMINAL CARE; TREATMENT OUTCOME;

ADULT; AGED; ANOREXIA; HUMANS; MIDDLE AGED; NEOPLASMS; NUTRITIONAL SUPPORT; PALLIATIVE CARE; PRACTICE GUIDELINES; QUALITY OF LIFE; TERMINAL CARE;

EID: 0035184640     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (137)

1. Dietetic suggestions for a patient at the end of his life
2. The sloganism of starvation
3. Treatment of the dying in the acute care hospital: Advanced dementia and metastatic cancer
4. Position of the American Dietetic Association: Issues in feeding the terminally ill adult
5. Home parenteral nutrition for patients with inoperable malignant bowel obstruction
6. Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials
7. Home parenteral nutrition in adults: A european multicentre survey in 1997
8. Should cancer patients with incurable disease receive parenteral or enteral nutritional support?
9. Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement
10. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer
11. Tube feeding in palliative care: Benefits and problems
12. Effects of artificial nutrition on the nutritional status of cancer patients
13. Home parenteral nutrition in cancer patients
14. Guidelines on artificial nutrition versus hydration in terminal cancer patients
15. Quality of life and lenght of survival in incurable cancer patients on home parenteral nutrition
16. Parenteral and enteral feeding in hospitals in Italy: A national survey
17. Withdrawing intensive life-sustaining treatment recommendations for compassionate clinical management
18. Dietitians' role in decisions to withhold nutrition and hydration
19. Hard choices: The gynecologic cancer patient's end-of-life preferences
20. Volume of hydration in terminal cancer patients
21. Estimate of survival of patients admitted to a palliative care unit: A prospective study
22. A randomized controlled trial of local injections of hyaluronidase versus placebo in cancer patients receiving subcutaneous hydration
23. Proctoclysis for hydration of terminally ill cancer patients
24. Placebo controlled trial of enteric coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head region
25. Feeding, withdrawing, and withholding: Ethical perspectives
26. Dehydration symptoms of palliative care cancer patients
27. Symptômes d'inconfort autres que la douleur en fin de vie
28. Palliative treatment of upper intestinal obstruction by gynecological malignancy: The usefulness of percutaneous endoscopic gastrostomy
29. Effects of administration of oral branched-chain amino acids on anorexia and caloric intake in cancer patients
30. Percutaneous endoscopic gastrostomy as a decompressive technique in bowel obstruction due to abdominal carcinomatosis
31. Dehydration in the terminally illiatrogenic insult or natural process?
32. An oncology patient's choice to forgo nonvolitional nutrition support: Ethical considerations
33. Extent and determinants of error in doctors' prognoses in terminally ill patients: Prospective cohort study
34. Percutaneous endoscopic gastrostomy and early mortality
35. Quality of life in oncology practice: Prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy
36. Race, nutritional status, and survival from breast cancer
37. Determinants in Canadian health care workers of the decision to withdraw life support from the critically ill
38. Outcome of cancer patients receiving home parenteral nutrition
39. Percutaneous gastrostomy for decompression in patients with advanced gynecologic malignancies
40. Percutaneous gastrotomy with fluoroscopic guidance: Single-center experience in 500 consecutive cancer patients
41. Education in cancer palliative care: Report from a consensus meeting supported by the EC « Europe Against Cancer » programme
42. European views on palliative care
43. Compared effects of enteral nutrition by percutaneous endoscopic gastrostomy in cancer and non-cancer patients: A long-term study
44. Standards, options et recommandations (SOR) pour l'utilisation des médicaments orexigènes en cancérologie
45. The symptoms of advanced cancer
46. On withholding nutrition and hydration in the terminally ill: Has palliative medicine gone too far? A reply
47. Dehydration and the dying patient
48. Care for dying patients
49. A randomized study of oral nutritional support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non-small-cell lung cancer
50. Hypodermoclysis (HDC) for symptom control vs the Edmonton Injector (EI)
51. How often can we justify parenteral nutrition in terminally ill cancer patients?
52. The use of hypodermoclysis for rehydration in terminally ill cancer patients
53. Subcutaneous infusion or hypodermoclysis: A practical approach
54. Méthodologie de développement des standards, options et recommandations diagnostiques et thérapeutiques en cancérologie
55. An observational study of the role of pain control and food adaptation of elderly patients with terminal cancer
56. Nutrition et hydratation des patients en fin de vie
57. The management of common symptoms in patients with advanced cancer
58. Serum albumin is predictive of 30-day survival after percutaneous endoscopic gastrostomy
59. Quality of life assessment: An independent prognostic variable for survival in lung cancer
60. Palliative effect of chemotherapy: Objective tumor response is associated with symptom improvement in patients with metastatic breast cancer
61. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: A randomized control trial
62. Démarche pour une décision éthique (DDE). Comment préparer en équipe la meilleure décision possible dans les situations de crises ou de fin de vie
63. Quality of life and nutritional support in patients with cancer
64. Dietary guidelines in perspective
65. Percutaneous endoscopic gastrostomy for decompression of the stomach and small bowel
66. Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma?
67. Nutrition support: Ethical or expedient, and who will choose?
68. Where do cancer patients die? Ten-year trends in the place of death of cancer patients in England
69. Home parenteral nutrition in patients with a cancer diagnosis
70. Home parenteral and enteral nutrition in cancer patients
71. Current use and clinical outcome of home parenteral and enteral nutrition therapies in the United States
72. Proceedings: Causes of death in cancer patients
73. Prognostic factors for survival in patients treated in phase I clinical trials
74. Oral and dental disease in terminally ill cancer patients
75. Oral carriage of yeasts, coliforms and staphylococci in patients with advanced malignant disease
76. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: What have we learned in a decade of experience?
77. Low serum albumin and increased risk of mortality after percutaneous endoscopic gastrostomy: Surprised?
78. Nutrition support in clinical practice: Review of published data and recommendations for future research directions National Institutes of Health, American Society for Parenteral and Enteral Nutrition, and American Society for Clinical Nutrition
79. Standards, options et recommandations pour une bonne pratique dans la prise en charge de la douleur du cancer chez l'adulte et l'enfant
80. The use of steroids in the management of inoperable intestinal obstruction in terminal cancer patients: Do they remove the obstruction?
81. Supportive care in oncology
82. Prospective evaluation of prognostic variables from patientcompleted questionnaires
83. Pretreatment prognostic factors for survival in small-cell lung cancer: A new prognostic index and validation of three known prognostic indices on 341 patients
84. Successful validation of the palliative prognostic score in terminally ill cancer patients
85. Biological indices predictive of survival in 519 Italian terminally ill cancer patients
86. Prediction of survival of patients terminally ill with cancer. Results of an Italian prospective multicentric study
87. Constipation in advanced cancer patients
88. Forgoing artificial nutrition and hydration: Legal and ethical considerations
89. Comfort care for terminally ill patients: The appropriate use of nutrition and hydratation
90. Provision of food and fluids in terminal care: A sociological analysis
91. Primary caregiver perceptions of intake cessation in patients who are terminally ill
92. Bowel obstruction in home-care cancer patients: 4 Years experience
93. Nutrition in cancer patients
94. Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction
95. Données épidémiologiques 1993-1995 de la nutrition parentérale à domicile en centres agréés chez l'adulte en France
96. Perceptions and decision-making on rehydration of terminally ill cancer patients and family members
97. The palliative prognostic index: A scoring system for survival prediction of terminally ill cancer patients
98. The sensation of thirst in dying patients receiving i.v. hydration
99. Standards, options et recommandations (SOR): Assistance nutritionnelle en onco-hématologie
100. Impact of weight loss, appetite, and the inflammatory response on quality of life in gastrointestinal cancer patients
101. Current applications of health-related quality-of-life assessment in oncology
102. Effect of dietary couseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: A prospective, randomized study
103. Artificial nutrition support in hospitals in United Kingdom, 1991: Second national survey
104. Artificial nutrition support in hospitals in the United Kingdom, 1994: Third national survey
105. Impact of home artificial nutrition on performance status in advanced cancer
106. Impact of home artificial nutrition on survival in advanced cancer
107. Home artificial nutrition in advanced cancer
108. A new palliative prognostic score: A first step for the staging of terminally ill cancer patients
109. L'assistance nutritionnelle et le cancer évolué
110. Current practices for management of oral mucositis in cancer patients
111. Clinical symptoms and length of survival in patients with terminal cancer
112. Home parenteral nutrition: A systematic review
113. Management of bowel obstruction in advanced cancer
114. Standards, options et recommandations pour l'utilisation des antiémétiques en cancérologie
115. Treatment decisions in palliative cancer care: Patients' preferences for involvement and doctors' knowledge about it
116. Are quality of life, patient preferences, and costs realistic outcomes for clinical trials?
117. Prediction of the survival of patients with advanced ovarian cancer according to a risk model based on a scoring system
118. Standards, options et recommandation: Nutrition artificielle à domicile du malade cancéreux adulte
119. Effect of psychosocial treatment on survival of patients with metastatic breast cancer
120. Prognostic factors in patients with metastatic cotorectal cancer receiving 5-fluorouracil and folinic acid
121. Methods of hydration in palliative care patients
122. Symptom control in advanced cancer
123. A critical, systematic analysis of the use of oral nutritional supplements in the community
124. Use of TPN in terminally ill cancer patients
125. La place de la nutrition artificielle à domicile chez le patient cancéreux
126. Home parenteral nutrition in adults: A multicentre survey in Europe 1993
127. Home parenteral nutrition in adults: A European multicenter survey in 1997
128. Unendurable symptoms as prognostic indicators of impending death in terminal cancer patients
129. Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer
130. Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6
131. The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer
132. Confirmation of a prognostic index for patients with inoperable non-small cell lung cancer
133. A practical prognostic index for inoperable non-small-cell lung cancer
134. Assessment of the quality of life of patients with advanced and end-stage cancer or serious infections with a symptom-based or an impact-based instrument
135. Use of resources and costs of palliative care with parenteral fluids and analgesics in the home setting for patients with end-stage cancer
136. Evaluation of patients with advanced cancer using the Karnofsky performance status